Which Products Actually Deserve to Travel
EXECUTIVE TAKEAWAYS
A product's success at home is evidence of fit with home-market consumers — it is not evidence of fit with the target market. Portfolio Selection has to be re-established with local market evidence every time.
Selection is comparative, not binary. The question is never ""is this product good?"" but ""is this product a stronger fit for this specific market, against this specific competitive set, than the rest of the range?""
A lean, evidenced initial range protects distributor confidence and commercial momentum; an unfiltered export of the home portfolio creates dead stock, diluted marketing spend, and a weaker channel relationship from the first shipment onward.
STRATEGIC CONTEXT
International expansion decisions become progressively more specific: where to compete, what to compete with, and finally which products to actually take forward. It is this last decision that determines whether the first six months in a new market build momentum or waste it. Portfolio Selection matters because a market and a category can both be correctly chosen while the specific SKUs carried into that market are still misjudged — priced for the wrong consumer, packaged in a format the channel doesn't stock, or absent the flavour the market has already shown it wants. Getting this decision right is what turns a market-entry plan into a market-entry range that a distributor can actually sell.
COMMON EXECUTIVE MISTAKE
The most consequential error is assuming the home-market portfolio should travel largely intact — that if the market and category have been validated, the products simply follow. This substitutes internal familiarity for external evidence. Teams default to exporting whatever performs best domestically because it is the least effortful decision available, not because it is the best-supported one. The result is a range selected on the strength of home-market conviction rather than on what the target market's own competitive set demonstrates it will actually buy.
MARKET & OPERATIONAL REALITY
Portfolio Selection is not a paperwork exercise — it determines the operational shape of the launch. It decides what the distributor is asked to hold in inventory, what marketing budget concentrates behind, which regulatory and labelling work has to be completed before goods can be imported, and what sequence products enter in. A SKU carried without evidence of market fit does not sit neutrally in the range; it consumes shelf space, distributor attention and promotional budget that a better-matched product could have used instead, and if it fails to move, it damages the channel relationship the whole entry depends on.
WHAT GOOD LOOKS LIKE
Disciplined Portfolio Selection follows a clear progression: build external market evidence first, only then lay the brand's own portfolio against it, compare SKUs against one another rather than assessing them in isolation, rate each on the strength of that comparison, flag the one critical barrier standing between each selected SKU and the shelf, and let that evidence — not internal preference — produce the final shortlist. The output is not a smaller copy of the home range; it is a market-specific range with a stated rationale and a known barrier attached to every product in it.
PRACTICAL BUSINESS EXAMPLE
An illustrative protein brand enters a new market carrying its full home range for consideration. Market mapping shows Chocolate and Vanilla in 1kg powder tubs dominate the category's top sellers — both are rated Lead. A Matcha flavour, absent from any competitor's range, is rated Differentiation, with consumer education identified as the barrier to budget for in the first ninety days. A Mango RTD format is also rated Differentiation, contingent on the distributor's cold-chain capability. The brand's 2kg tub — its best seller at home — is rated Hold, because that size doesn't appear anywhere in the competitive set and is likely priced beyond the market's first-purchase threshold. The recommended shortlist is five SKUs, not the full range, each carried forward for a specific, evidenced reason.
STRATEGIC RECOMMENDATIONS
Before finalising a launch range, map the target market's competitive set across sizing, format and flavour using publicly available bestseller, distributor and social-listening data — before looking at the brand's own portfolio at all. Rate every exportable SKU against that evidence rather than against internal sales performance at home. Require at least two matched variables before a product qualifies for the initial range. Separate Lead SKUs, which carry demonstrated acceptance, from Differentiation plays, which carry upside but require activation investment, and resource them differently. Attach one named barrier to every selected SKU and resolve it before commitment, not after shipment. Keep the initial range lean rather than comprehensive, and treat products that don't clear the evidence bar as deferred, not discarded — they can be revisited once the brand is established.
APPLYING THIS THROUGH THE SAMANA INSIGHTS FRAMEWORKS
Portfolio Selection sits downstream of Market Prioritisation and Category Prioritisation: where to compete, what to compete with, and only then, which specific products to take forward. It requires its own evidence base because a validated market and a validated category do not, on their own, validate any individual SKU. The framework's discipline is to build the external picture — what the market's leading and adjacent competitors actually sell, across sizing, format and flavour — before the brand's own portfolio enters the analysis at all, and to force every SKU through a comparative rating rather than a standalone judgment. That sequencing is what allows resource allocation, launch sequencing and distributor commitments to be built on market evidence rather than on which products the team knows best.
The question is not which products can we sell in this market. It is which products has the market itself already told us deserve to go first.
